Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and …
Medical - Instruments & Supplies
DE, Jena [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
Metric | Q3 | Q4 | Δ in % | |
---|---|---|---|---|
Current Ratio | 100.00 | 2.13 | 0.00 | |
Debt/Assets | n.A. | n.A. | n.A. | |
Debt/Equity | n.A. | n.A. | n.A. | |
Net Debt/EBITDA | 550.99 | 1.66 | 0.26 | |
Naive Interpretation | member |
2
Per Share
Metric | Q3 | Q4 | Δ in % | |
---|---|---|---|---|
Book Value | 100.00 | 22.92 | 0.00 | |
Cash | 32.24 | 0.23 | 0.17 | |
Capex | 0.00 | 0.00 | 0.00 | |
Free Cash Flow | 1236.94 | 0.42 | -0.03 | |
Revenue | 7.47 | 6.46 | 6.01 | |
Naive Interpretation | member |
3
Profitability
Metric | Q3 | Q4 | Δ in % | |
---|---|---|---|---|
Gross Margin | -8.01 | 0.50 | 0.54 | |
Operating Margin | inf | 0.00 | 0.10 | |
ROA | 100.00 | 0.02 | 0.00 | |
ROE | 83.64 | 0.03 | 0.02 | |
ROIC | inf | 0.00 | 0.02 | |
Naive Interpretation | member |
4
Valuation
The "Valuation Entry" for the Focus of CZMWY is permitted for members.
5
Growth
The "Growth Entry" for the Focus of CZMWY is permitted for members.
6
Leverage & Liquidity